State-of-the-art for CAR T-cell therapy for chronic lymphocytic leukemia in 2019
Abstract Experience in the use of CAR T cells to treat CLL is limited, but safety and efficacy data are encouraging, suggesting that it may be possible to use CAR T cells in populations of CLL patients with particularly unfavorable prognoses. Mechanisms intrinsic to the pathophysiology of CLL undoub...
| 發表在: | Journal for ImmunoTherapy of Cancer |
|---|---|
| Main Authors: | , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
BMJ Publishing Group
2019-08-01
|
| 主題: | |
| 在線閱讀: | http://link.springer.com/article/10.1186/s40425-019-0686-x |